American International Group’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-17,708
Closed -$2.48M 3067
2018
Q4
$2.48M Sell
17,708
-137
-0.8% -$20.8K 0.01% 910
2018
Q3
$3.05M Buy
17,845
+549
+3% +$92.3K 0.01% 914
2018
Q2
$3M Buy
17,296
+2,684
+18% +$403K 0.01% 899
2018
Q1
$1.69M Sell
14,612
-786
-5% -$83.6K 0.01% 1031
2017
Q4
$1.3M Buy
15,398
+226
+1% +$18.8K ﹤0.01% 1210
2017
Q3
$1.4M Buy
15,172
+2,751
+22% +$214K ﹤0.01% 1153
2017
Q2
$996K Buy
12,421
+2,672
+27% +$148K ﹤0.01% 1292
2017
Q1
$410K Buy
9,749
+2,081
+27% +$85.7K ﹤0.01% 1728
2016
Q4
$246K Sell
7,668
-20
-0.3% -$513 ﹤0.01% 2056
2016
Q3
$201K Buy
7,688
+11
+0.1% +$288 ﹤0.01% 2161
2016
Q2
$178K Buy
7,677
+3,119
+68% +$77.7K ﹤0.01% 2205
2016
Q1
$125K Hold
4,558
﹤0.01% 3235
2015
Q4
$130K Sell
4,558
-8
-0.2% -$215 ﹤0.01% 3260
2015
Q3
$80K Buy
4,566
+5
+0.1% +$98 ﹤0.01% 3657
2015
Q2
$82.2K Buy
4,561
+2,285
+100% +$31.2K ﹤0.01% 3802
2015
Q1
$28.3K Hold
2,276
﹤0.01% 4214
2014
Q4
$26.7K Buy
+2,276
New +$26.5K ﹤0.01% 4222

Other funds holding LOXO

American International Group's LOXO Position: Q1 2019 in Review

American International Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 17,708 shares — an estimated $2.48M sold.

American International Group first reported a position in LOXO in Q4 2014 and held it in 17 quarters. The position peaked at $3.05M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • American International Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • American International Group sold 17,708 Loxo Oncology, Inc shares in Q1 2019, an estimated $2.48M.
  • American International Group first reported a position in Loxo Oncology, Inc in Q4 2014 and held it in 17 quarters.
  • American International Group's Loxo Oncology, Inc position peaked at $3.05M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on American International Group's 13F filing for Q1 2019, filed 6 May 2019.